1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. DaShenLin Pharmaceutical Group Co., Ltd.
  6. Summary
    603233   CNE100002RG2

DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

(603233)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-08-11
30.36 CNY   -2.35%
06/22Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
05/06UBS Adjusts Dashenlin Pharmaceutical's Price Target to 40 Yuan From 73.5 Yuan, Keeps at Buy
MT
04/27DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
31.92 31.67 30.88 31.09 30.36 Last
3144707 2286101 3124546 3394645 2608369 Volume
-2.00% -0.78% -2.49% +0.68% -2.35% Change
Estimated financial data (e)
Sales 2022 19 899 M 2 951 M 2 951 M
Net income 2022 1 009 M 150 M 150 M
Net cash position 2022 511 M 75,8 M 75,8 M
P/E ratio 2022 24,9x
Yield 2022 1,64%
Sales 2023 24 905 M 3 694 M 3 694 M
Net income 2023 1 325 M 196 M 196 M
Net cash position 2023 773 M 115 M 115 M
P/E ratio 2023 21,1x
Yield 2023 2,18%
Capitalization 28 815 M 4 273 M 4 273 M
EV / Sales 2022 1,42x
EV / Sales 2023 1,13x
Nbr of Employees 38 353
Free-Float 33,4%
More Financials
Company
DaShenLin Pharmaceutical Group Co., Ltd. is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The Company mainly conducts its business within domestic market. 
Sector
Drug Retailers
Calendar
08/30Earnings Release
More about the company
Ratings of DaShenLin Pharmaceutical Group Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
06/22Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
05/06UBS Adjusts Dashenlin Pharmaceutical's Price Target to 40 Yuan From 73.5 Yuan, Keeps at..
MT
04/27DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End..
CI
04/27DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter..
CI
2021DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
2021Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2021Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter..
CI
2021Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End..
CI
2020DaShenLin Pharmaceutical Group Co., Ltd. cancelled the acquisition of 51% stake in Nant..
CI
2020Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
2020Secretive High-Speed Trading Firm Hits Jackpot With TikTok
DJ
2020Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2020Certain A Shares of DaShenLin Pharmaceutical Group Co., Ltd. are subject to a Lock-Up A..
CI
2020DaShenLin Pharmaceutical Group Co., Ltd. Announces Cash Dividend for the Year 2019, Pay..
CI
2020Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End..
CI
More news
News in other languages on DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
06/22Pékin envisage d'interdire aux entreprises de soins de santé sur Internet de vendre des..
04/27DaShenLin Pharmaceutical Group Co., Ltd. annonce ses résultats pour l'année complète se..
04/27DaShenLin Pharmaceutical Group Co., Ltd. annonce ses résultats pour le premier trimestr..
2020DaShenLin Pharmaceutical Group Co., Ltd. annonce un dividende en espèces pour l'année 2..
More news
Analyst Recommendations on DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
More recommendations
Chart DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
Duration : Period :
DaShenLin Pharmaceutical Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 30,36 CNY
Average target price 39,33 CNY
Spread / Average Target 29,5%
EPS Revisions
Managers and Directors
Guo Qiang Ke General Manager
Yun Feng Ke Chairman
Zhi Hui Chen Chairman-Supervisory Board
Guo Chang Liu Independent Director
Xiao Qiang Yang Independent Director